SUTTI, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 2.287
EU - Europa 1.982
AS - Asia 1.248
SA - Sud America 157
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 61
OC - Oceania 2
Totale 5.828
Nazione #
US - Stati Uniti d'America 2.220
RU - Federazione Russa 467
SG - Singapore 383
IE - Irlanda 314
IT - Italia 313
DE - Germania 284
CN - Cina 229
HK - Hong Kong 191
VN - Vietnam 160
SE - Svezia 155
BR - Brasile 117
FR - Francia 107
UA - Ucraina 95
GB - Regno Unito 76
IN - India 76
FI - Finlandia 61
KR - Corea 46
BD - Bangladesh 43
ID - Indonesia 34
CA - Canada 30
PL - Polonia 27
BJ - Benin 25
BE - Belgio 21
AR - Argentina 20
NL - Olanda 20
TR - Turchia 19
JP - Giappone 18
MX - Messico 18
ZA - Sudafrica 13
AT - Austria 10
ES - Italia 9
IQ - Iraq 8
CZ - Repubblica Ceca 7
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
JM - Giamaica 5
JO - Giordania 5
DZ - Algeria 4
EC - Ecuador 4
IR - Iran 4
LT - Lituania 4
MA - Marocco 4
NG - Nigeria 4
NP - Nepal 4
PY - Paraguay 4
NI - Nicaragua 3
PH - Filippine 3
SA - Arabia Saudita 3
VE - Venezuela 3
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
KE - Kenya 2
LB - Libano 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GY - Guiana 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MD - Moldavia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.739
Città #
San Jose 313
Dublin 305
Council Bluffs 194
Hong Kong 190
Jacksonville 161
Singapore 147
Ashburn 144
Dearborn 82
Beijing 68
Munich 65
Chandler 59
Columbus 58
Los Angeles 54
Moscow 50
Ho Chi Minh City 48
Santa Clara 46
Seoul 45
Milan 44
Lauterbourg 42
Novara 42
Wilmington 42
New York 41
Turin 38
Hanoi 34
Lawrence 33
Princeton 33
Phoenix 32
Dallas 29
Jakarta 28
Buffalo 27
Piemonte 27
Cotonou 25
Ann Arbor 23
Bremen 21
Brussels 20
Grafing 20
St Louis 20
Strasbourg 20
Warsaw 20
Brooklyn 19
Frankfurt am Main 19
Dong Ket 18
Helsinki 18
London 18
Atlanta 13
Monmouth Junction 13
Nuremberg 13
San Mateo 13
Tokyo 13
Andover 12
Boston 12
Denver 12
Falkenstein 12
Houston 12
Orem 12
The Dalles 12
Amsterdam 11
Guangzhou 11
Stockholm 11
Chennai 10
Johannesburg 10
Kocaeli 10
Mumbai 10
Poplar 10
Rome 10
São Paulo 10
Hangzhou 9
Nanjing 9
Tianjin 9
Toronto 9
Vercelli 9
Chicago 8
Haiphong 8
Mexico City 8
Montreal 8
Odalengo Grande 8
Kunming 7
Mülheim 7
Olathe 7
Redondo Beach 7
Schaumburg 7
Turku 7
Woodbridge 7
Assago 6
Augusta 6
Brasília 6
Charlotte 6
Gdynia 6
Genoa 6
Leawood 6
Manchester 6
Miami 6
Vienna 6
Ankara 5
Baghdad 5
Berlin 5
Brno 5
Da Nang 5
Las Vegas 5
Oklahoma City 5
Totale 3.263
Nome #
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 185
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis 170
Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis 161
Role of Balanced Involvement of the ICOS/ICOSL/Osteopontin Network in Cutaneous Wound Healing 159
CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation 157
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis 154
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice 152
CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury 152
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH) 149
Adaptive immunity: an emerging player in the progression of NAFLD 147
From MASLD to HCC: What's in the middle? 146
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 143
Adenosine A2a receptor stimulation prevents hepatocyte lipotoxicity and nonalcoholic steatohepatitis (NASH) in rats. 141
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH 138
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 137
CYP2E1 autoantibodies in liver diseases 126
The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: A 2015 update 123
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 122
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 122
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. 122
Is there a role for adaptive immunity in nonalcoholic steatohepatitis? 118
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein 118
Notch signaling and progenitor/ductular reaction in steatohepatitis. 117
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 111
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 110
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 110
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 108
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 108
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. 106
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts 105
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis 103
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 102
Conformational anti-cytochrome P4502E1 auto-antibodies contributes to necro-inflammatory injury in chronic hepatitis C 98
Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry 96
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets 96
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 95
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 95
Liver inflammation and regeneration in drug-induced liver injury: Sex matters! 94
Interplay between oxidative stress and steatosis in the progression of Hepatitis C 93
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease 91
NF-kB1 deficiency stimulates the progression of nonalcoholic steatohepatitis (NASH) in mice by promoting NKT-mediated responses 88
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 88
Immune response against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α in heavy drinkers 82
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 81
The paradox role of cytotoxic T-lymphocytes in NAFLD-associated hepatocellular carcinoma 80
Editorial: Inflammatory responses on the road from NASH to HCC: pathogenic mechanisms and possible therapeutic strategies 79
Inflammatory processes involved in NASH-related hepatocellular carcinoma 75
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses 71
ICOSL: more than a trigger of ICOS function 63
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion 35
Dietary Fructose Alters Duodenal Mucin Glycosylation and Mucus Production in High-Fat Diet-Fed Mice 33
When the Liver Flares: Inflammatory and Immunometabolic Mechanisms Driving the Transition from MASLD to MASH 32
Letter to the Editor: Xietu Hemu prescription: A novel therapeutic strategy for obesity and metabolic dysfunction-associated steatotic liver disease? 26
Diets Differently Affect Bone Health: Murine Models 15
Totale 5.828
Categoria #
all - tutte 27.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022266 0 0 0 10 17 31 35 7 19 24 49 74
2022/2023690 75 31 39 14 49 66 31 21 316 2 33 13
2023/2024242 18 21 13 3 35 7 50 5 9 5 43 33
2024/2025729 8 8 45 12 31 64 102 76 117 59 26 181
2025/20262.482 106 116 149 296 260 155 371 369 173 251 139 97
2026/2027667 93 204 199 171 0 0 0 0 0 0 0 0
Totale 5.828